Zhenglin Chang | Urological | Young Scientist Award

Posted on by Phenomenological Research Awards

Mr. Zhenglin Chang | Urological | Young Scientist Award

Physician at The First Affiliated Hospital of Guangzhou Medical University, China.

Dr. Zhenglin Chang 🎓 is a Ph.D. candidate in Clinical Laboratory Diagnostics at Guangzhou Medical University and Guangzhou Laboratory. With a strong background in surgery (M.Sc.) and medical imaging (B.Sc.), he has published 25 SCI papers (19 as first/co-first author) with a cumulative impact factor of 137.96. His research focuses on urological disease diagnostics and clinical translation, integrating multi-omics analysis, AI-based predictive modeling, and rapid detection technologies. He has secured multiple research grants, presented at international conferences, and holds several patent applications. Beyond research, he actively mentors students and contributes as a peer reviewer for prestigious journals. 📚🔬

Professional Profile:

Scopus

Suitability for Young Scientist Award

Dr. Zhenglin Chang is highly suitable for the Young Scientist Award due to his outstanding research contributions, publication record, and leadership in clinical laboratory diagnostics. His multidisciplinary expertise in molecular diagnostics, AI-driven predictive modeling, and rapid detection technologies has significantly advanced the field of urological disease diagnostics.

Dr. Zhenglin Chang 🎓 is a Ph.D. candidate in Clinical Laboratory Diagnostics at Guangzhou Medical University and Guangzhou Laboratory. With a strong background in surgery (M.Sc.) and medical imaging (B.Sc.), he has published 25 SCI papers (19 as first/co-first author) with a cumulative impact factor of 137.96. His research focuses on urological disease diagnostics and clinical translation, integrating multi-omics analysis, AI-based predictive modeling, and rapid detection technologies. He has secured multiple research grants, presented at international conferences, and holds several patent applications. Beyond research, he actively mentors students and contributes as a peer reviewer for prestigious journals. 📚🔬

🎓 Education & Experience

  • 📍 Ph.D. (2022-Present) – Guangzhou Medical University / Guangzhou Laboratory | Clinical Laboratory Diagnostics
  • 🎓 M.Sc. (2019-2022) – Guangzhou Medical University | Surgery
  • 🏥 B.Sc. (2014-2019) – Chongqing Medical University | Medical Imaging
  • 🏥 Clinical Experience – Licensed surgeon with expertise in urological procedures and diagnostic imaging.

📈 Professional Development (100 Words)

Dr. Zhenglin Chang actively engages in cutting-edge research on urological diseases, combining molecular diagnostics, bioinformatics, and clinical data analysis. He has successfully led six industry-funded projects and two university-funded research initiatives, securing a total funding of ¥820,000. His expertise spans single-cell sequencing, next-generation sequencing (NGS), and advanced imaging techniques, with a strong focus on rapid diagnostics. He has presented at international conferences, delivered oral presentations, and contributed as a reviewer for leading journals like J Transl Med, Eur Urol Open Sci, and Microb Pathog. His research directly impacts early disease detection and precision medicine applications. 🧬📊🔬

🔬 Research Focus (100 Words)

Dr. Zhenglin Chang specializes in urological disease diagnostics and clinical translation, particularly in sepsis, urinary tract infections (UTIs), and bladder cancer. His work integrates molecular mechanisms, AI-driven clinical diagnostics, and high-throughput sequencing to enhance early disease detection. His contributions include optimizing urosepsis rat models, developing high-coverage tNGS panels for rapid UTI detection, and designing laser scattering pathogen detection systems. He has also established a 30,000+ patient diagnostic database to support machine learning-based predictive models for disease prognosis. His research aims to revolutionize point-of-care testing and precision medicine for urological diseases. 🏥🧪💡

🏆 Awards & Honors

  • 🏅 2024 – National Graduate Scholarship, Guangzhou Medical University
  • 🏅 2024 – 3rd Prize, National Career Planning Competition (Guangzhou Medical University Finals)
  • 🏅 2024 – Outstanding Graduate Student Award, Guangzhou Medical University
  • 🏅 Multiple – University-level scholarships & Outstanding Student Leader award
  • 🏅 Scientific Excellence – Recognized for multiple high-impact publications and research contributions.

Publication Top Notes

📄 L. An, S. Li, Z. Chang, X. Duan, W. Wu (2025). “Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet.” Gut Microbes. 📑

📄 Y. Chen, E. Li, Q. Yang, Z.J. Cheng, B. Sun (2025). “Predicting Time to First Rejection Episode in Lung Transplant Patients Using a Comprehensive Multi-Indicator Model.” Journal of Inflammation Research. 📑

Ahmet Özdemir | Medicinal Chemistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Prof Dr. Ahmet Özdemir | Medicinal Chemistry | Best Researcher Award

Prof Dr Anadolu University Turkey

Prof. Dr. Ahmet Özdemir is a distinguished scholar in Medicinal Chemistry at Anadolu University, Faculty of Pharmacy. Born on July 24, 1972, in Muğla, Turkey, he has been contributing significantly to the field through his research, teaching, and administrative roles. With extensive experience in drug development and chemical synthesis, Prof. Özdemir has been recognized for his impactful work in medicinal chemistry. He is married and a father of two sons. 📚🧪

 

Profile

scopus

Education

Prof. Özdemir completed his primary and secondary education in Salihli, Turkey, before pursuing his undergraduate studies at Anadolu University Faculty of Pharmacy (1990-1994). He earned his Master’s degree in Pharmaceutical Chemistry (1995-1996) and his Ph.D. (1996-2004) from the same institution. His Master’s thesis focused on 2-substituted-1H-phenantro[9,10-d]imidazole compounds, and his Ph.D. research centered on synthesizing pyrazoline derivatives for their biological activities. 🎓📖

Experience

Prof. Özdemir began his academic career as a Research Assistant at Anadolu University in 1997. He has progressed through roles including Research Assistant Doctor, Lecturer, Assistant Professor, and Associate Professor. Since 2015, he has served as a Professor at the same university. His administrative roles include Associate Director of Yunus Emre Vocational School and Vice Academic Director of the Open Education Faculty. 🏛️👨‍🏫

Research Interests

Prof. Özdemir’s research interests lie in Medicinal Chemistry, focusing on drug development and synthesis of novel compounds with therapeutic potentials. His work includes designing and evaluating small molecules for targeted therapies, especially for cancer and inflammatory diseases. He employs various chemical techniques to develop new medicinal agents and study their biological effects. 🔬💊

Awards

Prof. Özdemir has received several accolades for his research contributions, including the Anadolu University Article Performance Awards (2014-2020) and the ISIF’21 Silver Medal for his invention related to lung cancer treatment. These awards highlight his excellence in research and innovation. 🏆🎖️

Publications Top Notes

Prof. Özdemir has an extensive publication record in high-impact journals. Notable publications include:

Özdemir A., et al., Molecules, 2022

Altıntop M.D., et al., Archiv der Pharmazie, 2022

Altıntop M.D., et al., European Journal of Medicinal Chemistry, 2022

Temel H.E., et al., Turk J Biochem, 2023

Altıntop M.D., et al., International Journal of Molecular Sciences, 2023

Altıntop M.D., et al., Archiv der Pharmazie, 2023